Michael Messinger
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
14 Feb 2023 |
25,000 |
25,000
|
-
|
|
-
|
Options (Right to Buy) |
Cary W. Sucoff
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 May 2022 |
42,000 |
42,000
|
-
|
|
-
|
Options (Right to Buy) |
Sol J. Barer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 May 2022 |
42,000 |
42,000
|
-
|
|
-
|
Options (Right to Buy) |
Steven C. Gilman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 May 2022 |
42,000 |
42,000
|
-
|
|
-
|
Options (Right to Buy) |
Michael J. Otto
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 May 2022 |
42,000 |
42,000
|
-
|
|
-
|
Options (Right to Buy) |
David N. Low
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 May 2022 |
42,000 |
42,000
|
-
|
|
-
|
Options (Right to Buy) |
Lishan Aklog
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 May 2022 |
42,000 |
42,000
|
-
|
|
-
|
Options (Right to Buy) |
Jane F. Barlow
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
17 May 2022 |
42,000 |
42,000
|
-
|
|
-
|
Options (Right to Buy) |
Roger J. Pomerantz
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
500,000 |
500,000
|
-
|
|
-
|
Options (Right to Buy) |
Michael Messinger
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
165,000 |
165,000
|
-
|
|
-
|
Options (Right to Buy) |
Natalie Bogdanos
|
General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
125,000 |
125,000
|
-
|
|
-
|
Options (Right to Buy) |
Cara Cassino
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Feb 2022 |
160,000 |
160,000
|
-
|
|
-
|
Options (Right to Buy) |
Sol J. Barer
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 May 2021 |
25,000 |
25,000
|
-
|
|
-
|
Options (Right to Buy) |
Steven C. Gilman
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 May 2021 |
25,000 |
25,000
|
-
|
|
-
|
Options (Right to Buy) |
Michael J. Otto
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 May 2021 |
25,000 |
25,000
|
-
|
|
-
|
Options (Right to Buy) |
Cary W. Sucoff
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 May 2021 |
25,000 |
25,000
|
-
|
|
-
|
Options (Right to Buy) |
David N. Low
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 May 2021 |
25,000 |
25,000
|
-
|
|
-
|
Options (Right to Buy) |
Lishan Aklog
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 May 2021 |
25,000 |
25,000
|
-
|
|
-
|
Options (Right to Buy) |
Michael Messinger
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Apr 2021 |
80,000 |
80,000
|
-
|
|
-
|
Options (Right to Buy) |
Roger J. Pomerantz
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Apr 2021 |
254,000 |
254,000
|
-
|
|
-
|
Options (Right to Buy) |
Natalie Bogdanos
|
General Counsel |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Apr 2021 |
70,000 |
70,000
|
-
|
|
-
|
Options (Right to Buy) |
Cara Cassino
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Apr 2021 |
90,000 |
90,000
|
-
|
|
-
|
Options (Right to Buy) |
Cara Cassino
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Apr 2021 |
80,000 |
80,000
|
-
|
|
-
|
Options (Right to Buy) |
Jane F. Barlow
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Feb 2021 |
16,000 |
16,000
|
-
|
|
-
|
OPTIONS (RIGHT TO BUY) |
Lishan Aklog
|
None |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Jun 2020 |
16,000 |
16,000
|
-
|
|
-
|
Options (Right to Buy) |
Michael Messinger
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Jun 2020 |
75,000 |
75,000
|
-
|
|
-
|
Options (Right to Buy) |
Michael Messinger
|
Chief Financial Officer |
Purchase of securities on an exchange or from another person at price $ 0.37 per share. |
13 Dec 2019 |
5,000 |
19,091
(0%)
|
0%
|
0.4 |
1,850
|
Common Stock, par value $0.0001 per share |
David N. Low
|
None |
Purchase of securities on an exchange or from another person at price $ 0.43 per share. |
13 Dec 2019 |
300,000 |
370,550
(0%)
|
0%
|
0.4 |
129,000
|
Common Stock, par value $0.0001 per share |
Cary W. Sucoff
|
None |
Purchase of securities on an exchange or from another person at price $ 0.39 per share. |
13 Dec 2019 |
50,000 |
62,000
(0%)
|
0%
|
0.4 |
19,500
|
Common Stock, par value $0.0001 per share |
Natalie Bogdanos
|
General Counsel |
Purchase of securities on an exchange or from another person at price $ 1.24 per share. |
25 Jul 2017 |
800 |
800
(0%)
|
0%
|
1.2 |
992
|
Common Stock, par value $0.0001 per share |
Cara Cassino
|
Chief Medical Officer |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
25 Jul 2017 |
4,000 |
4,000
|
-
|
|
-
|
Warrants (Right to Buy) |
Cara Cassino
|
Chief Medical Officer |
Purchase of securities on an exchange or from another person at price $ 1.24 per share. |
25 Jul 2017 |
8,000 |
8,000
(0%)
|
0%
|
1.2 |
9,920
|
Common Stock, par value $0.0001 per share |
Joshua Muntner
|
SVP Business Development |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
25 Jul 2017 |
1,000 |
1,000
|
-
|
|
-
|
Warrants (Right to Buy) |
Joshua Muntner
|
SVP Business Development |
Purchase of securities on an exchange or from another person at price $ 1.24 per share. |
25 Jul 2017 |
2,000 |
2,000
(0%)
|
0%
|
1.2 |
2,480
|
Common Stock, par value $0.0001 per share |
Natalie Bogdanos
|
General Counsel |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
25 Jul 2017 |
400 |
400
|
-
|
|
-
|
Warrants (Right to Buy) |
Michael Messinger
|
SVP Finance |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
25 Jul 2017 |
400 |
400
|
-
|
|
-
|
Warrants (Right to Buy) |
Sol J. Barer
|
None |
Purchase of securities on an exchange or from another person at price $ 1.24 per share. |
25 Jul 2017 |
40,000 |
815,933
(1%)
|
0%
|
1.2 |
49,600
|
Common Stock, par value $0.0001 per share |
Sol J. Barer
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
25 Jul 2017 |
20,000 |
20,000
|
-
|
|
-
|
Warrants (Right to Buy) |
Steven C. Gilman
|
Director, CEO |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
25 Jul 2017 |
400 |
400
|
-
|
|
-
|
Warrants (Right to Buy) |
Steven C. Gilman
|
Director, CEO |
Purchase of securities on an exchange or from another person at price $ 1.24 per share. |
25 Jul 2017 |
800 |
20,800
(0%)
|
0%
|
1.2 |
992
|
Common Stock, par value $0.0001 per share |
Lisa Ricciardi
|
None |
Purchase of securities on an exchange or from another person at price $ 1.24 per share. |
25 Jul 2017 |
9,600 |
9,600
(0%)
|
0%
|
1.2 |
11,904
|
Common Stock, par value $0.0001 per share |
Lisa Ricciardi
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
25 Jul 2017 |
4,800 |
4,800
|
-
|
|
-
|
Warrants (Right to Buy) |
Michael J. Otto
|
None |
Purchase of securities on an exchange or from another person at price $ 1.24 per share. |
25 Jul 2017 |
8,000 |
8,000
(0%)
|
0%
|
1.2 |
9,920
|
Common Stock, par value $0.0001 per share |
Michael J. Otto
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
25 Jul 2017 |
4,000 |
4,000
|
-
|
|
-
|
Warrants (Right to Buy) |
Isaac Blech
|
None |
Purchase of securities on an exchange or from another person at price $ 1.24 per share. |
25 Jul 2017 |
16,000 |
16,000
(0%)
|
0%
|
1.2 |
19,840
|
Common Stock, par value $0.0001 per share |
Cary W. Sucoff
|
None |
Purchase of securities on an exchange or from another person at price $ 1.24 per share. |
25 Jul 2017 |
12,000 |
12,000
(0%)
|
0%
|
1.2 |
14,880
|
Common Stock, par value $0.0001 per share |
Cary W. Sucoff
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
25 Jul 2017 |
6,000 |
6,000
|
-
|
|
-
|
Warrants (Right to Buy) |
David N. Low
|
None |
Purchase of securities on an exchange or from another person at price $ 1.24 per share. |
25 Jul 2017 |
40,000 |
70,550
(0%)
|
0%
|
1.2 |
49,600
|
Common Stock, par value $0.0001 per share |
David N. Low
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
25 Jul 2017 |
20,000 |
20,000
|
-
|
|
-
|
Warrants (Right to Buy) |
Roger J. Pomerantz
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
25 Jul 2017 |
400 |
400
|
-
|
|
-
|
Warrants (Right to Buy) |
Roger J. Pomerantz
|
None |
Purchase of securities on an exchange or from another person at price $ 1.24 per share. |
25 Jul 2017 |
800 |
800
(0%)
|
0%
|
1.2 |
992
|
Common Stock, par value $0.0001 per share |
Michael Messinger
|
SVP Finance |
Purchase of securities on an exchange or from another person at price $ 1.24 per share. |
25 Jul 2017 |
800 |
14,091
(0%)
|
0%
|
1.2 |
992
|
Common Stock, par value $0.0001 per share |
Isaac Blech
|
None |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
25 Jul 2017 |
8,000 |
8,000
|
-
|
|
-
|
Warrants (Right to Buy) |
Steven C. Gilman
|
Director, CEO |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
27 Jul 2016 |
20,000 |
20,000
|
-
|
|
-
|
Common Stock, par value $0.0001 per share |
Steven C. Gilman
|
Director, CEO |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
27 Jul 2016 |
20,000 |
20,000
|
-
|
|
-
|
Warrants (Right to Buy) |
Nancy Dong
|
VP Controller |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
31 Dec 2015 |
3,333 |
0
|
-
|
|
-
|
Class B Warrants (Right to Buy) |
Daniel Couto
|
SVP Manufacturing & Facilities |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
17 Nov 2015 |
2,872 |
0
|
-
|
|
-
|
Common Stock, par value $0.0001 per share |
Daniel Couto
|
SVP Manufacturing & Facilities |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
03 Nov 2015 |
2,867 |
2,872
|
-
|
|
-
|
Common Stock, par value $0.0001 per share |
Daniel Couto
|
SVP Manufacturing & Facilities |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
20 Oct 2015 |
2,867 |
5,739
|
-
|
|
-
|
Common Stock, par value $0.0001 per share |
Daniel Couto
|
SVP Manufacturing & Facilities |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
06 Oct 2015 |
2,867 |
8,606
|
-
|
|
-
|
Common Stock, par value $0.0001 per share |
Daniel Couto
|
SVP Manufacturing & Facilities |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
22 Sep 2015 |
2,867 |
11,473
|
-
|
|
-
|
Common Stock, par value $0.0001 per share |
Daniel Couto
|
SVP Manufacturing & Facilities |
Sale of securities on an exchange or to another person at price $ 0.00 per share. |
08 Sep 2015 |
2,867 |
14,340
|
-
|
|
-
|
Common Stock, par value $0.0001 per share |
Julia P. Gregory
|
CEO |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
02 Mar 2015 |
11,778 |
50,283
|
-
|
|
-
|
Common Stock, par value $0.0001 per share |
Julia P. Gregory
|
CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Sep 2014 |
29,946 |
38,505
|
-
|
|
-
|
Common Stock, par value $0.0001 per share |
Nancy Dong
|
VP Controller |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Sep 2014 |
6,287 |
15,161
|
-
|
|
-
|
Common Stock, par value $0.0001 per share |
Michael Messinger
|
VP Finance |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Sep 2014 |
13,291 |
13,291
|
-
|
|
-
|
Common Stock, par value $0.0001 per share |
Barry Kappel
|
SVP Business Development |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Sep 2014 |
12,532 |
12,532
|
-
|
|
-
|
Common Stock, par value $0.0001 per share |
Daniel Couto
|
SVP Manufacturing & Facilities |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Sep 2014 |
17,207 |
17,207
|
-
|
|
-
|
Common Stock, par value $0.0001 per share |
Michael Wittekind
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Sep 2014 |
17,893 |
17,893
|
-
|
|
-
|
Common Stock, par value $0.0001 per share |
David Huang
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
11 Sep 2014 |
23,901 |
23,901
|
-
|
|
-
|
Common Stock, par value $0.0001 per share |